The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes
Abstract
One of the major manifestations of obesity is increased production of the adipocyte-derived 16-kDa peptide leptin, which is also elevated in heart disease, including congestive heart failure. However, whether leptin can directly alter the cardiac phenotype is not known. We therefore studied the effect of leptin as a potential hypertrophic factor in cultured myocytes from 1- to 4-day-old neonatal rat heart ventricles. Using RT-PCR, we demonstrate that these cells express the short-form (OB-Ra) leptin receptor. Twenty-four hours of exposure to leptin (0.31 to 31.3 nmol/L) produces a significantly increased cell surface area that peaked at 0.63 nmol/L. Subsequent experiments were done with 3.1 nmol/L leptin, which significantly increased cell area by 42%, protein synthesis by 32%, and α-skeletal actin and myosin light chain-2 expression by 250% and 300%, respectively. These events occurred in the absence of any increased cell death. Hypertrophy was preceded by rapid activation of the mitogen-activated protein kinase system including p38 and p44/42 as early as 5 minutes after leptin addition, whereas hypertrophy was inhibited by the p38 inhibitor SB203580 but not by the p44/42 inhibitor PD98059. Our results demonstrate a direct hypertrophic effect of leptin and may offer a biological link between hypertrophy and hyperleptinemic conditions such as obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several reports have suggested that leptin directly induced hypertrophy in both human and rodent cardiomyocytes (217, 292, 293, 379).”
From Cardiac remodeling in obesity (2008) · cites this paper as [292]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Divergent Signaling Capacities of the Long and Short Isoforms of the Leptin Receptor
Bjørbæk, C., Uotani, S., da Silva, B., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32686 · Cited by 890
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. A. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 821
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 684
Mechanisms of Obesity-Associated Cardiovascular and Renal Disease
Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200209000-00003 · Cited by 373
Zechner, D., Thuerauf, D. J., Hanford, D. S., McDonough, P. M., & Glembotski, C. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.115 · Cited by 313
Yue, T., Gu, J.-L., Wang, C., Reith, A. D., Lee, J. C., Mirabile, R. C., Kreutz, R. H., Wang, Y., Maleeff, B. E., Parsons, A. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007037200 · Cited by 195
Leptin Attenuates Cardiac Contraction in Rat Ventricular Myocytes
Nickola, M. W., Wold, L. E., Colligan, P. B., Wang, G., Samson, W. K., & Ren, J. T. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.501 · Cited by 185
Paolisso, G., Tagliamonte, M. R., Galderisi, M., Zito, G. A., Petrocelli, A., Carella, C., DIVITIIS, O. D., & Varricchio, M. (1999) · Hypertension · doi:10.1161/01.hyp.34.5.1047 · Cited by 156
Cited by
Sorted by citations
Items 101–200 of 248
The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage
Mulè, G., & Cerasola, G. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.04716.x · Cited by 36
Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor
Akasaka, Y., Tsunoda, M., Ogata, T., Ide, T., & Murakami, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.06.009 · Cited by 35
Rajapurohitam, V., Izaddoustdar, F., Abundis, E. M., & Karmazyn, M. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.025 · Cited by 35
Self-citationFontes‐Carvalho, R., Pimenta, J. M., Bettencourt, P., Leite-Moreira, A. F., & Azevedo, A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1019468 · Cited by 35
Sinoatrial node dysfunction induces cardiac arrhythmias in diabetic mice
Soltysinska, E., Speerschneider, T., Winther, S. V., & Thomsen, M. B. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0122-y · Cited by 35
Xia, Y., & Karmazyn, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065185 · Cited by 34
Self-citationElectrophysiological Characterization of Left Ventricular Myocytes from Obese Sprague‐Dawley Rat
Ricci, E., Smallwood, S., Chouabe, C., Mertani, H. C., Raccurt, M., Morel, G., & Bonvallet, R. (2006) · Obesity · doi:10.1038/oby.2006.90 · Cited by 33
Understanding Obesity-Related High Output Heart Failure and Its Implications
Shen, Q., Hiebert, J. B., Rahman, F. K., Krueger, K. J., Gupta, B. P., & Pierce, J. D. (2021) · International Journal of Heart Failure · doi:10.36628/ijhf.2020.0047 · Cited by 33
Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
Kim, H. ‐., Kang, J., Jeung, E., & Yang, M. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14570 · Cited by 32
Obesity-related cardiorenal disease: the benefits of bariatric surgery
Fenske, W., Athanasiou, T., Harling, L., Drechsler, C., Darzi, A. W., & Ashrafian, H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.145 · Cited by 32
Obesity – a risk factor or a RISK factor for myocardial infarction?
Heusch, G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706833 · Cited by 31
Effects of leptin on cardiovascular physiology
Tune, J. D., & Considine, R. V. (2007) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2007.04.001 · Cited by 31
Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta
Rider, O. J., Lewis, A., & Neubauer, S. (2014) · Obesity Facts · doi:10.1159/000368429 · Cited by 33
Sexual dimorphism in obesity-mediated left ventricular hypertrophy
Böhm, C., Benz, V., Clemenz, M., Sprang, C., Hoeft, B., Kintscher, U., & Foryst‐Ludwig, A. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00593.2012 · Cited by 31
Relation of Serum Leptin With Cardiac Mass and Left Atrial Dimension in Individuals >70 Years of Age
Lieb, W., SULLIVAN, L. M., Aragam, J. R., Harris, T. B., Roubenoff, R., Benjamin, E. J., & Vasan, R. S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.026 · Cited by 30
Kamimura, D., Suzuki, T., Wang, W., deShazo, M. D., Hall, J. E., Winniford, M. D., Kullo, I. J., Mosley, T. H., Butler, K. R., & Hall, M. E. (2018) · Hypertension Research · doi:10.1038/s41440-018-0062-0 · Cited by 30
The endocrinological component and signaling pathways associated to cardiac hypertrophy
Takano, A. P. C., Senger, N., & Barreto‐Chaves, M. L. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110972 · Cited by 30
Zheng, J., Ji, F., Yin, Y., Wang, X., Ren, A., Bai, J., Sun, X., Yuan, W., & Li, L. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05415.x · Cited by 30
The heart in obesity-hypertension
Morse, S. A., Bravo, P. E., Morse, M. C., & Reisin, E. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.4.647 · Cited by 31
Abundis, E. M., Rajapurohitam, V., Haist, J. V., Gan, X. T., & Karmazyn, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041612 · Cited by 28
Self-citationLeptin, a mediator of cardiac damage associated with obesity
Martínez‐Martínez, E., Jurado-López, R., Cervantes-Escalera, P., Cachofeiro, V., & Miana, M. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0060 · Cited by 27
Adipokines, Vascular Wall, and Cardiovascular Disease
Maresca, F., Palma, V. D., Bevilacqua, M., Uccello, G., Taglialatela, V., Giaquinto, A., Esposito, G., Trimarco, B., & Cirillo, P. L. (2014) · Angiology · doi:10.1177/0003319713520463 · Cited by 27
Ghantous, C. M., Kobeissy, F. H., Soudani, N., Rahman, F. A., Al-Hariri, M., Itani, H. A., Sabra, R., & Zeidan, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00240 · Cited by 28
Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin
Adiarto, S., Emoto, N., Iwasa, N., & Yokoyama, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.066 · Cited by 28
Lin, Y., Chen, Y., Huang, J.-H., Lin, Y., Huang, S.-S., Chen, S.-A., & Chen, Y. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-94 · Cited by 27
Chao, H., Hong, H.-J., Liu, J., Lin, J., Chen, Y., Chiu, W., Wu, C., Shyu, K., & Cheng, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.051 · Cited by 27
Valladolid‐Acebes, I. (2024) · Biomedicines · doi:10.3390/biomedicines12112422 · Cited by 28
Hou, N., Luo, M., Liu, S., Zhang, H., Xiao, Q., Sun, P., Zhang, G., Luo, J., & Chen, M. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05442.x · Cited by 25
Puurunen, V.-P., Lepojärvi, E. S., Piira, O.-P., Hedberg, P., Junttila, J. M., Ukkola, O. H., & Huikuri, H. V. (2016) · Peptides · doi:10.1016/j.peptides.2016.08.002 · Cited by 25
Chen, M., Wang, J., Lee, C., & Hsu, B. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s172231 · Cited by 25
Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide
Mascareno, E. J., Beckles, D. L., Dhar-Mascareño, M., & Siddiqui, M. A. Q. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.06.005 · Cited by 24
The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat
Dixon, R. A., Davidson, S. M., Wynne, A. M., Yellon, D. M., & Smith, C. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819d6152 · Cited by 23
Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis
Kshatriya, S., Reams, G. P., Spear, R. M., Freeman, R. H., Dietz, J. R., & Villarreal, D. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328332fb49 · Cited by 24
Leptin Expression in Dogs with Cardiac Disease and Congestive Heart Failure
Fonfara, S., Hetzel, U., Tew, S. R., Dukes‐McEwan, J., Cripps, P., & Clegg, P. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.00782.x · Cited by 24
Obese Subjects Show Sex-Specific Differences in Right Ventricular Hypertrophy
Rider, O. J., Lewis, A., Lewandowski, A. J., Ntusi, N., Nethononda, R. M., Petersen, S. E., Francis, J. M., Pitcher, A., Banerjee, R., Leeson, P., et al. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.002454 · Cited by 23
Bruder-Nascimento, T. B., Kress, T. C., & de Chantemèle, E. J. B. (2019) · F1000Research · doi:10.12688/f1000research.20150.1 · Cited by 23
Impact of Weight-Loss Medications on the Cardiovascular System
Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23
Moey, M., Rajapurohitam, V., Zeidan, A., & Karmazyn, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182600 · Cited by 23
Self-citationGómez‐Hurtado, N., Domínguez‐Rodríguez, A., Matéo, P., Fernández‐Velasco, M., Val‐Blasco, A., Aizpún, R., Sabourin, J., Gomez, A. M., Bénitah, J., & Delgado, C. (2017) · The Journal of Physiology · doi:10.1113/jp274030 · Cited by 23
Leptin protects the cardiac myocyte cultures from hypoxic damage
Erkasap, N., İkizler, M., Shneyvays, V., Zinman, T., Mamedova, L. K., Uyar, R., & Shainberg, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.039 · Cited by 23
Rajapurohitam, V., Kilić, A., Javadov, S. A., & Karmazyn, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1307-x · Cited by 22
Self-citationObesity and sudden cardiac death: Prevalence, pathogenesis, prevention and intervention
Yao, Y., Jia, X., & Li, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1044923 · Cited by 25
Modulation of the cardiovascular system by leptin
Abel, E. D., & Sweeney, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.019 · Cited by 22
Leptin-induced cardiomyocyte hypertrophy is associated with enhanced mitochondrial fission
Jong, C. J., Yeung, J., Tseung, E., & Karmazyn, M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3450-5 · Cited by 24
Self-citationObesity, Hypertension, and the Heart
Good, D., Morse, S. A., Ventura, H. O., & Reisin, E. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00011.x · Cited by 22
Kyrou, I., Mattu, H. S., Chatha, K. K., & Randeva, H. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00007-5 · Cited by 21
Weng, J., Jiang, S., Ding, L., Xu, Y., Zhu, X., & Jin, P. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14005 · Cited by 19
Chen, H., Li, M., Liu, L., Zhu, D., & Tian, G. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220908215 · Cited by 20
Sawaguchi, T., Nakajima, T., Haruyama, A., Hasegawa, T., Shibasaki, I., Nakajima, T., Kaneda, H., Arikawa, T., Obi, S., Sakuma, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225008 · Cited by 20
Matsui, H., Yokoyama, T., Tanaka, C., Sunaga, H., Koitabashi, N., Takizawa, T., Arai, M., & Kurabayashi, M. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-37 · Cited by 19
Xia, Q.-G., Na, T., Guo, Y., Bi, Y.-T., Zhang, H., & Dai, D. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00503.x · Cited by 19
Simvastatin inhibits leptin-induced hypertrophy in cultured neonatal rat cardiomyocytes1
Tai-ping, H. U., Xu, F., Li, Y., & Luo, J. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00300.x · Cited by 18
Huisamen, B., Hafver, T. L., Lumkwana, D., & Lochner, A. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6665-2 · Cited by 18
Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects
Mulè, G., Nardi, E., Cottone, S., Cusimano, P., Incalcaterra, F., Giandalia, M. E., Palermo, A., Mezzatesta, G., & Cerasola, G. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.011 · Cited by 18
Leptin stimulates sympathetic axon outgrowth
Pellegrino, M. J., McCully, B. H., & Habecker, B. A. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.014 · Cited by 17
Rubio, B., Mora, C., Pintado, C., Mazuecos, L., Fernández, A., López, V., Andrés, A., & Gallardo, N. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154453 · Cited by 16
Pathak, A., Smih, F., Galinier, M., Verwaerde, P., Rouet, P., Philip‐Couderc, P., Montastruc, J., & Sénard, J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802751 · Cited by 17
Rietdorf, K., & MacQueen, H. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13678 · Cited by 15
The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism
Mao, Y., Zhao, K., Li, P., & Sheng, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04562-6 · Cited by 14
Huang, J., Li, G.-A., Wang, J., Jiao, Y., Qian, Z.-F., Fan, L., & Tang, L.-M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01230-7 · Cited by 15
Karmazyn, M., Gan, X. T., & Rajapurohitam, V. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0057 · Cited by 16
Self-citationPiñeiro, R., Iglesias, M. J., Eirás, S., Viñuela, J. E., Lago, F., & González‐Juanatey, J. R. (2005) · Endocrine Research · doi:10.1080/07435800500456937 · Cited by 13
Roncalli, J. G., Smih, F., Desmoulin, F., Dumonteil, N., Harmancey, R., Hennig, S., Perez, L., Pathak, A., Galinier, M., MASSABUAU, P., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.11.007 · Cited by 15
Cardiac hypertrophy with obesity is augmented after pregnancy in C57BL/6 mice
Che, C., Dudick, K., & Shoemaker, R. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0269-z · Cited by 14
Xia, Y., Javadov, S. A., Gan, T. X., Pang, T., Cook, M. A., & Karmazyn, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110494 · Cited by 14
Self-citationObesity, Leptin, and Incident Heart Failure
Deswal, A. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.030 · Cited by 14
Fat-to-heart crosstalk in health and disease
Lodewijks, F., McKinsey, T. A., & Robinson, E. L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.990155 · Cited by 13
Left ventricle relative wall thickness and plasma leptin levels
Blasio, A. D., Donato, F., Stefano, A. D., Gallina, S., Granieri, M., Napolitano, G., Petrella, V., Riccardi, I., Santarelli, F., Valentini, P., et al. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e57813 · Cited by 13
Wu, H., Yeh, Y., Kuo, W., Huang, S., Kuo, W., Hsieh, D. J., Wu, C., Tsai, C., Lee, S., & Huang, C. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1443 · Cited by 13
Karmazyn, M., & Gan, X. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021137 · Cited by 12
Self-citationPathways to Myocardial Hypertrophy
Kontaridis, M. I., Geladari, E. V., & Geladari, C. V. (2014) · Springer eBooks · doi:10.1007/978-3-319-08798-6_10 · Cited by 13
Dzenkeviciute, V., Petrulionienė, Ž., Šapoka, V., Aidietienė, S., & Abaraviciute, L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1294-y · Cited by 12
From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
Romero-Becerra, R., Santamans, A. M., Arcones, A. C., & Sabio, G. (2023) · Physiology · doi:10.1152/physiol.00018.2023 · Cited by 12
Adipokines in obesity and metabolic diseases
Giammanco, M., Marini, H. R., Pallio, S., Giammanco, M. M., Tomasello, G., Carini, F., Venturella, F., Leto, G., & Guardia, M. L. (2021) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2020.8915 · Cited by 11
Adipocytokines: Emerging therapeutic targets for pain management
Gao, S., Liu, D.-Q., Li, D., Sun, J., Zhang, L.-Q., Wu, J., Song, F., Zhou, Y., & Mei, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112813 · Cited by 11
Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
Han, X., Zhang, Y., Zhang, X., Ji, H., Wang, W., Qiao, O., Li, X., Wang, J., Liu, C., Huang, L., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106257 · Cited by 11
Exploring the Mechanistic Link Between Obesity and Heart Failure
Özkan, B., & Ndumele, C. E. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01526-y · Cited by 12
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 11
Adipokines and the Right Ventricle: The MESA-RV Study
Harhay, M. O., Kizer, J. R., Criqui, M. H., Lima, J. A. C., Tracy, R. P., Bluemke, D. A., & Kawut, S. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136818 · Cited by 10
Gómez-Crisóstomo, N. P., la Cruz-Hernández, E. N. D., Méndez, E. R. M., Hernández-Landero, M. F., Liévano, J. U. C., & Abundis, E. M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1517181 · Cited by 10
Cardioprotective properties of leptin in patients with excessive body mass
Paduszyńska, A., Sakowicz, A., Banach, M., Maciejewski, M., Dąbrowa, M., & Bielecka-Dabrowa, A. M. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02211-9 · Cited by 9
Berzabá-Evoli, E., Zazueta, C., Hernández, J. H. C., Gómez-Crisóstomo, N. P., Juárez-Rojop, I. E., la Cruz-Hernández, E. N. D., & Abundis, E. M. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6081415 · Cited by 9
Bo, B., Guo, A., Kaila, S. J., Hao, Z., Zhang, H., Wei, J., & Yao, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1170324 · Cited by 11
Cingolani, H. E., Pérez, N. G., Caldiz, C. I., Garciarena, C. D., Giusti, V. C. D., Correa, M. V., Villa‐Abrille, M. C., Yeves, A. M., Ennis, I. L., de Cingolani, G. C., et al. (2009) · Springer eBooks · doi:10.1007/978-90-481-2850-1_13 · Cited by 8
Should We Target Obesity in Advanced Heart Failure?
Vest, A. R., & Young, J. B. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0284-z · Cited by 8
Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?
Vašků, J. B., Hlinomaz, O., & Vašků, A. (2007) · Heart and Vessels · doi:10.1007/s00380-007-0980-2 · Cited by 8
Cano-Martínez, L. J., Marroquín, C., Coral‐Vázquez, R. M., Méndez, J. P., Trejo, S., Pérez, F. J. C., Pérez-Razo, J. C., & Canto, P. (2019) · Gene · doi:10.1016/j.gene.2019.03.070 · Cited by 7
Piestrzeniewicz, K., Maciejewski, M., & Goch, J. H. (2008) · Cited by 7
Obesity and Mechanisms of its Negative Impact on the Cardiovascular System
Miklishanskaya, S. V., Solomasova, L. V., & Mazur, M. A. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-02-09 · Cited by 6
Chiu, C.-Z., Wang, B.-W., & Shyu, K. (2013) · Clinical Science · doi:10.1042/cs20130235 · Cited by 6
Xu, M., Ji, H., Dai, D., Tang, X., & Dai, Y. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.6.0009 · Cited by 5
Melaku, L. S., & Nebi, T. D. (2019) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_104_17 · Cited by 6
Perpétuo, L., Voisin, P., Amado, F. M. L., Hirtz, C., & Vitorino, R. M. P. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.019 · Cited by 5
Wang, Y., Wang, D., Jin, H., Min, Y., & Zhang, L. (2018) · 中医杂志:英文版 · doi:10.1016/j.jtcm.2017.04.001 · Cited by 5
Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy
Gao, Z., Bao, J., Hu, Y., Tu, J., Ye, L., & Wang, L. (2023) · Current Drug Targets · doi:10.2174/1389450124666230907115831 · Cited by 4
Relationship Between Leptin and Heart Failure: A Meta-Analysis
Sun, X., Xin, C., Yao, J., & Wang, H. (2025) · Global Heart · doi:10.5334/gh.1434 · Cited by 4
Karmazyn, M., & Gan, X. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010003 · Cited by 5
Self-citationAbel, E. D., Ahima, R. S., Anderson, E. J., Berg, D. D., Berger, J. S., Das, S., Feinberg, M. W., Fisher, E. A. A., Garshick, M. S., Giannarelli, C., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.325798 · Cited by 4
Weight Loss Drugs and Cardiovascular Risks
Poirier, P. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0148-y · Cited by 4
Metadata
- Authors
- Rajapurohitam, V., Gan, X. T., Kirshenbaum, L. A., & Karmazyn, M.
- Affiliations
- Western University (CA)
- Venue
- Circulation Research
- Published
- 2003-08-22
- Volume
- 93
- Issue
- 4
- Pages
- 277-279
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2116649734
- Cited by
- 248
- References
- 22
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 17 · 2013: 13 · 2012: 14
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canada Research Chairs
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- leptin, cardiac hypertrophy, ventricular myocytes, neonatal rat heart, leptin receptor, Ob-Ra, mitogen-activated protein kinase, p38 MAPK, p44/42 MAPK, alpha-skeletal actin, myosin light chain 2, obesity, congestive heart failure, protein synthesis
- MeSH terms
- Animals, Animals, Newborn, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Inhibitors, Flavonoids, Gene Expression Regulation, Heart Ventricles, Imidazoles, Obesity, Pyridines, Receptors, Cell Surface, RNA, Messenger, Blotting, Western, Mitogen-Activated Protein Kinase 1, Leptin, Mitogen-Activated Protein Kinases, Myocytes, Cardiac, p38 Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Cell Size, Rats, Receptors, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review